1. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives
   Yulin Ren et al, 2021, Bioorganic & Medicinal Chemistry CrossRef
2. Norcantharidin-blocked ANXA2P2 inhibits fibroblast proliferation by increasing UBAP2L mRNA stability through LIN28B
   Rui Huang et al, 2021, Life Sciences CrossRef
3. Norcantharidin Nanostructured Lipid Carrier (NCTD-NLC) Suppresses the Viability of Human Hepatocellular Carcinoma HepG2 Cells and Accelerates the Apoptosis
   Zijun Yan et al, 2022, Journal of Immunology Research CrossRef
4. A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma
   Ming-Hua Xie et al, 2022, Frontiers in Oncology CrossRef
5. FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy
   Jiehua Deng et al, 2022, Frontiers in Genetics CrossRef
6. Norbornene and Related Structures as Scaffolds in the Search for New Cancer Treatments
   Gorka Calvo-Martín et al, 2022, Pharmaceuticals CrossRef
7. Norcantharidin overcomes vemurafenib resistance in melanoma by inhibiting pentose phosphate pathway and lipogenesis via downregulating the mTOR pathway
   Lei Wang et al, 2022, Frontiers in Pharmacology CrossRef
8. Traditional Chinese Medicine and Colorectal Cancer: Implications for Drug Discovery
   Qiang Sun et al, 2021, Frontiers in Pharmacology CrossRef